hycanthone methanesulfonate

structure

Networked: 3 relevant articles (1 outcomes, 0 trials/studies)

1.	Schistosomiasis (Bilharziasis) 01/01/1971 - "The efficacy of parenteral single-dose therapy of bilharziasis with hycanthone methanesulfonate."
2.	Sarcoma (Soft Tissue Sarcoma) 11/01/1979 - "Of the mice receiving hycanthone methanesulfonate and living 200 days or longer, hepatocellular carcinoma was seen in 11.5% and liver sarcoma was seen in 4.2%. "
3.	Neoplasms (Cancer) 11/01/1979 - "In addition, mice receiving hycanthone methanesulfonate showed a significantly higher incidence of both type 1 (43% compared to 21% in controls) and type 2 (21% compared to 12% in controls) hepatocyte neoplasms. "
4.	Lymphoma (Lymphomas) 11/01/1995 - "Mouse lymphoma cells of the L5178Y TK + /-3.7.2C line were exposed to varying concentrations of the anti-schistosomal drug hycanthone methanesulfonate. " 11/01/1995 - "Molecular analysis of the TK locus in L5178Y large and small colony mouse lymphoma cell mutants induced by hycanthone methanesulfonate."
5.	Hepatocellular Carcinoma (Hepatoma) 11/01/1979 - "Of the mice receiving hycanthone methanesulfonate and living 200 days or longer, hepatocellular carcinoma was seen in 11.5% and liver sarcoma was seen in 4.2%. "

1.	Therapeutics